Literature DB >> 25727965

Molecular typing of Sporothrix schenckii isolates from cats in Malaysia.

Rui Kano1, Miki Okubo, Han Hock Siew, Hiroshi Kamata, Atsuhiko Hasegawa.   

Abstract

Epidemiological data on the aetiologic agents of feline sporotrichosis in Malaysia have not been reported, though human sporotrichosis in Malaysia is reported to be transmitted primarily via cat scratch. To the best of our knowledge, the present report is the first study of the molecular epidemiology of Sporothrix schenckii isolates from cats with sporotrichosis in Malaysia. In the present work, we characterised 18 clinical isolates from cats in Malaysia based on molecular properties, including sequence analyses of the calmodulin gene and the rDNA ITS region and selective PCR of mating type (MAT) loci. In this study, isolates from feline sporotrichosis were identified as a S. schenckii sensu stricto by sequence analyses of the calmodulin gene and the internal transcribed spacer (ITS) region. Notably, phylogenetic analysis of the ITS confirmed assignment to clinical clade D (and not C) of S. schenckii sensu stricto. Therefore, clinical clade D of S. schenckii sensu stricto appeared to be the prevailing source of feline sporotrichosis in Malaysia. The ratio of MAT1-1-1:MAT1-2-1 in these Malaysian isolates was found to be 1 : 0. This result suggested that a clonal strain of S. schenckii is the prevailing causative agent of feline sporotrichosis in Malaysia.
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  Feline sporotrichosis; MAT 1-1-1; Sporothrix schenckii; mating type; molecular typing

Mesh:

Substances:

Year:  2015        PMID: 25727965     DOI: 10.1111/myc.12302

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  17 in total

Review 1.  Feline sporotrichosis in Asia.

Authors:  Hock Siew Han; Rui Kano
Journal:  Braz J Microbiol       Date:  2020-05-03       Impact factor: 2.476

2.  Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.

Authors:  Jéssica Sepulveda Boechat; Sandro Antonio Pereira; Ana Caroline de Sá Machado; Paula Gonçalves Viana; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira; Isabella Dib Ferreira Gremião; Manoel Marques Evangelista de Oliveira
Journal:  Braz J Microbiol       Date:  2020-07-02       Impact factor: 2.476

3.  Clinical, Epidemiological, and Epizootic Features of Sporothrix brasiliensis in Espírito Santo, Brazil.

Authors:  Bruno Carneiro Rediguieri; Isabela da Cruz Bahiense; Jamile Ambrósio de Carvalho; Gustavo Rocha Leite; Aloísio Falqueto; Anderson Messias Rodrigues; Sarah Santos Gonçalves
Journal:  Ecohealth       Date:  2022-02-21       Impact factor: 3.184

4.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management.

Authors:  Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo
Journal:  An Bras Dermatol       Date:  2022-09-22       Impact factor: 2.113

Review 5.  Guideline for the management of feline sporotrichosis caused by Sporothrix brasiliensis and literature revision.

Authors:  Isabella Dib Ferreira Gremião; Elisabeth Martins da Silva da Rocha; Hildebrando Montenegro; Aroldo José Borges Carneiro; Melissa Orzechowski Xavier; Marconi Rodrigues de Farias; Fabiana Monti; Wilson Mansho; Romeika Herminia de Macedo Assunção Pereira; Sandro Antonio Pereira; Leila M Lopes-Bezerra
Journal:  Braz J Microbiol       Date:  2020-09-29       Impact factor: 2.476

6.  Antifungal activity of Acylhydrazone derivatives against Sporothrix spp.

Authors:  Jhon Jhamilton Artunduaga Bonilla; Leandro Honorato; Krupanandan Haranahalli; Isabella Dib Ferreira Gremião; Sandro Antonio Pereira; Allan Guimarães; Andrea Regina de Souza Baptista; Patricia de M Tavares; Marcio L Rodrigues; Kildare Miranda; Iwao Ojima; Maurizio Del Poeta; Leonardo Nimrichter
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.938

7.  Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics.

Authors:  Rosane Orofino-Costa; Priscila Marques de Macedo; Anderson Messias Rodrigues; Andréa Reis Bernardes-Engemann
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

8.  Cell walls of the dimorphic fungal pathogens Sporothrix schenckii and Sporothrix brasiliensis exhibit bilaminate structures and sloughing of extensive and intact layers.

Authors:  Leila M Lopes-Bezerra; Louise A Walker; Gustavo Niño-Vega; Héctor M Mora-Montes; Gabriela W P Neves; Hector Villalobos-Duno; Laura Barreto; Karina Garcia; Bernardo Franco; José A Martínez-Álvarez; Carol A Munro; Neil A R Gow
Journal:  PLoS Negl Trop Dis       Date:  2018-03-09

9.  Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens.

Authors:  Anderson Messias Rodrigues; Geisa Ferreira Fernandes; Leticia Mendes Araujo; Paula Portella Della Terra; Priscila Oliveira dos Santos; Sandro Antonio Pereira; Tânia Maria Pacheco Schubach; Eva Burger; Leila Maria Lopes-Bezerra; Zoilo Pires de Camargo
Journal:  PLoS Negl Trop Dis       Date:  2015-08-25

10.  Feline sporotrichosis: associations between clinical-epidemiological profiles and phenotypic-genotypic characteristics of the etiological agents in the Rio de Janeiro epizootic area.

Authors:  Jéssica Sepulveda Boechat; Manoel Marques Evangelista Oliveira; Rodrigo Almeida-Paes; Isabella Dib Ferreira Gremião; Ana Caroline de Sá Machado; Raquel de Vasconcelos Carvalhaes Oliveira; Anna Barreto Fernandes Figueiredo; Vanessa Brito de Souza Rabello; Karoline Benevides de Lima Silva; Rosely Maria Zancopé-Oliveira; Tânia Maria Pacheco Schubach; Sandro Antonio Pereira
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-03       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.